Price Chart

Executive Summary

Baxter entered into Amendment No. 2 to its credit agreement, relaxing the net leverage ratio covenant for the next five quarters (maintaining it at 4.25x through Sep 2027 instead of stepping down) and removed a subsidiary borrower. Separately, the company completed a $600M cash tender offer for four series of senior notes, upsized from $500M, retiring ~$864M in principal at a discount. The covenant relief signals near-term financial strain, while the debt buyback at a discount is a modest credit positive, reducing interest expense and extending runway.

Key Financial Metrics

Key Facts

• Baxter amended its credit agreement to keep the maximum net leverage ratio at 4.25x through September 30, 2027, instead of stepping down to 4.00x in Sep 2027 and 3.75x thereafter.
• Baxter completed a $600M cash tender offer (upsized from $500M) for four series of senior notes, accepting $864M in principal at a discount.
• The tender offer accepted 100% of tendered 3.132% notes due 2051 ($422M), 3.500% notes due 2046 ($132M), and 4.500% notes due 2043 ($73M), plus 31.37% of tendered 2.539% notes due 2032 ($237M).
• Baxter World Trade SRL was removed as a borrower under the credit agreement.
• The company paid an early tender premium of $30 per $1,000 principal amount.
• No Final Settlement Date will occur; all notes tendered after Aug. 17, 2026 will be returned.

Financial Impact

Baxter retired ~$864M in principal for $600M in cash, a ~$264M discount. The covenant relaxation provides breathing room on leverage through Sep 2027.

Risk Factors

• Leverage may remain elevated, constraining financial flexibility.
• The company's dividend was recently cut to $0.01/share, indicating ongoing cash preservation.
• Forward-looking statements highlight risks from supply chain, inflation, and competition.

Market Snapshot

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

US Market Status